These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 18307840)

  • 1. Optimization of intranasal corticosteroid formulations for the treatment of allergic rhinitis.
    Wingertzahn MA; Derebery MJ; Nelson HS
    Allergy Asthma Proc; 2007; 28 Suppl 1():S18-24. PubMed ID: 18307840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient and physician perspectives on the attributes of nasal allergy medications.
    Naclerio RM; Hadley JA; Stoloff S; Nelson HS
    Allergy Asthma Proc; 2007; 28 Suppl 1():S11-7. PubMed ID: 18307839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal corticosteroids in the treatment of allergic rhinitis.
    Ratner PH; Stoloff S; Meltzer EO; Hadley JA
    Allergy Asthma Proc; 2007; 28 Suppl 1():S25-32. PubMed ID: 18307841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ciclesonide, a hypotonic intranasal corticosteroid.
    Neffen H; Wingertzahn MA
    Allergy Asthma Proc; 2010; 31 Suppl 1():S29-37. PubMed ID: 20557684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation considerations of intranasal corticosteroids for the treatment of allergic rhinitis.
    Meltzer EO
    Ann Allergy Asthma Immunol; 2007 Jan; 98(1):12-21. PubMed ID: 17225715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of sensory perceptions and patient preference for intranasal corticosteroid sprays in allergic rhinitis.
    Khanna P; Shah A
    Am J Rhinol; 2005; 19(3):316-21. PubMed ID: 16011141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient preferences and sensory comparisons of three intranasal corticosteroids for the treatment of allergic rhinitis.
    Bachert C; El-Akkad T
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):292-7. PubMed ID: 12269650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient preferences for sensory attributes of intranasal corticosteroids and willingness to adhere to prescribed therapy for allergic rhinitis: a conjoint analysis.
    Mahadevia PJ; Shah S; Leibman C; Kleinman L; O'Dowd L
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):345-50. PubMed ID: 15521370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Intranasal Corticosteroid Sensory Attributes and Patient Preference for Fluticasone Furoate for the Treatment of Allergic Rhinitis.
    May JR; Dolen WK
    Clin Ther; 2019 Aug; 41(8):1589-1596. PubMed ID: 31402060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluticasone furoate: a new intranasal corticosteroid.
    Kumar R; Kumar D; Parakh A
    J Postgrad Med; 2012; 58(1):79-83. PubMed ID: 22387656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of intranasal steroid spray (mometasone furoate) on treatment of patients with seasonal allergic rhinitis: comparison with oral corticosteroids.
    Karaki M; Akiyama K; Mori N
    Auris Nasus Larynx; 2013 Jun; 40(3):277-81. PubMed ID: 23127728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of action of intranasal corticosteroids.
    Mygind N; Nielsen LP; Hoffmann HJ; Shukla A; Blumberga G; Dahl R; Jacobi H
    J Allergy Clin Immunol; 2001 Jul; 108(1 Suppl):S16-25. PubMed ID: 11449202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal corticosteroids: the role of patient preference and satisfaction.
    Sher ER; Ross JA
    Allergy Asthma Proc; 2014; 35(1):24-33. PubMed ID: 24433594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of patients' preferences for triamcinolone acetonide aqueous, fluticasone propionate, and mometasone furoate nasal sprays in patients with allergic rhinitis.
    Stokes M; Amorosi SL; Thompson D; Dupclay L; Garcia J; Georges G
    Otolaryngol Head Neck Surg; 2004 Sep; 131(3):225-31. PubMed ID: 15365540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing rhinitis: Strategies for improved patient outcomes.
    Carr WW; Nelson MR; Hadley JA
    Allergy Asthma Proc; 2008; 29(4):349-57. PubMed ID: 18702880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis.
    Lohia S; Schlosser RJ; Soler ZM
    Allergy; 2013; 68(5):569-79. PubMed ID: 23590215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciclesonide nasal spray: in allergic rhinitis.
    Dhillon S; Wagstaff AJ
    Drugs; 2008; 68(6):875-83. PubMed ID: 18416590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory procedures. Part 6--Use of nasal sprays in allergic rhinitis.
    Burns D
    Nurs Times; 2007 Sep 11-17; 103(37):24-5. PubMed ID: 17902591
    [No Abstract]   [Full Text] [Related]  

  • 19. Fluticasone furoate (Veramyst) for allergic rhinitis.
    Med Lett Drugs Ther; 2007 Nov; 49(1273):90-2. PubMed ID: 17975524
    [No Abstract]   [Full Text] [Related]  

  • 20. Symptomatic treatment of pollen-related allergic rhinoconjunctivitis in children: randomized controlled trial.
    Wartna JB; Bohnen AM; Elshout G; Pijnenburg MW; Pols DH; Gerth van Wijk RR; Bindels PJ
    Allergy; 2017 Apr; 72(4):636-644. PubMed ID: 27696447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.